Friday, June 26, 2026
ADVT 
National

Three bodies recovered from B.C. park where mountaineers went missing

Darpan News Desk The Canadian Press, 08 Jul, 2024 03:10 PM
  • Three bodies recovered from B.C. park where mountaineers went missing

Three bodies were recovered Monday from British Columbia's Garibaldi Provincial Park where a trio of mountaineers went missing more than a month ago.

In a statement released by Squamish RCMP, BJ Chute, the manager of Squamish Search and Rescue, said the team worked with police to carry out the recovery operation in the Atwell Peak area on the edge of Mount Garibaldi.

RCMP did not release the names of those who died, saying their families have requested privacy.

The three mountaineers were last seen on May 31 in terrain that Squamish Search and Rescue member Christy Allan described as "really complex and remote."

The early days of the search operation were hampered by poor weather conditions, including a high avalanche risk and low visibility in the backcountry area about 70 kilometres north of Vancouver.

At the time, Allan said search members would usually access the area by air and ground, but the winter conditions made it difficult. A crew was able to make it to the shelter at Elfin Lakes in the park, she said, but they later had to pull back.

On June 6, nearly a week after the trio went missing, Squamish Search and Rescue shared an update saying helicopters, groundcrews, drones and avalanche dogs were involved in the effort to find them. It said one helicopter was equipped with a rescue-signal detector, though low cloud cover continued to hamper the search.

A subsequent update later that day said the team had temporarily suspended the search, while another advisory two days later said they hadn't completely stopped looking. 

The June 8 statement said the team was switching tactics, opting to review aerial video footage given the "dangerous terrain" and conditions on the ground.

The RCMP and BC Coroners Service are now investigating the deaths.

MORE National ARTICLES

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer
Earlier in the day, Musk made an offer to buy 100 per cent of Twitter at $54.20 per share, a 54 per cent premium over the closing price of Twitter on January 28, 2022, the trading day before Musk began investing in the company. This is a 38 per cent premium over the closing price of Twitter on April 1, 2022, the trading day before Musk's investment in Twitter was publicly announced.

Twitter board to evaluate Musk's 'unsolicited, non-binding' $43B offer

Feds to target need with housing cash, Hussen says

Feds to target need with housing cash, Hussen says
Housing Minister Ahmed Hussen said the budget's plan to double housing starts over the next decade will aim to incentivize the construction of units needed by seniors who are downsizing, for example, as well as newcomer families.

Feds to target need with housing cash, Hussen says

B.C. fires, floods add uncertainty to spring thaw

B.C. fires, floods add uncertainty to spring thaw
Major wildfires, droughts and mudslides last year dramatically altered the landscape, raising questions about the river's ability to handle the spring thaw, or freshet.

B.C. fires, floods add uncertainty to spring thaw

Confirmed outbreak of avian flu in B.C.

Confirmed outbreak of avian flu in B.C.
She says all poultry producers, including backyard poultry owners, are advised to increase their biosecurity practices and carefully monitor their flocks for any sign of illness.

Confirmed outbreak of avian flu in B.C.

Singh demands Indian PM stop anti-Muslim hate

Singh demands Indian PM stop anti-Muslim hate
In an outspoken intervention into Indian politics, Singh says he is deeply concerned by images, videos and targeted threats of violence against the country's Muslim community.    

Singh demands Indian PM stop anti-Muslim hate

Health Canada approves COVID-19 prevention drug

Health Canada approves COVID-19 prevention drug
The drug, named Evusheld, is intended for people who cannot receive a typical vaccine or for whom vaccines alone won't provide enough immunity. AstraZeneca says the drug is not a substitute for vaccination against COVID-19 for most people.    

Health Canada approves COVID-19 prevention drug